LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

 Peninsula Participações and Endeavor Catalyst Lead US$10m Series B in Brazilian Healthtech Hilab (em português)

November 26, 2020
 Peninsula Participações and Endeavor Catalyst invest in Hilab

Peninsula Participações and Endeavor Catalyst led a US$10m Series B in Hilab (formerly Hi Technologies), a Brazilian manufacturer of portable blood test devices. The round implies a R$300m post-money valuation for Hilab, according to Brazil Journal.  monashees and Qualcomm Ventures invested R$14.7m previously.  Hilab launched a C19 diagnostic test and a portal for medical information related to C19 for Brazilian doctors and patients to better navigate the current pandemic. 

(Brazil Journal) – A Hilab está ganhando espaço no mercado de medicina diagnóstica com uma combinação que agrada tanto consumidores quanto investidores: 20 tipos de testes rápidos e um modelo de negócios asset light.

Fundada há quatro anos, a Hilab inventou um pequeno aparelho (o da foto acima) que é cedido em comodato a farmácias, consultórios, hospitais e prontos-socorros do SUS junto com um ‘kit de testes’ que contém os reagentes químicos.

Read more at Brazil Journal.

 Peninsula Participações and Endeavor Catalyst Lead US$10m Series B in Brazilian Healthtech Hilab (em português) was last modified: December 8th, 2020 by cramos
blood testBrazilC19diagnostic testEndeavor CatalystHealthtechHi TechnologiesHilabMarcus FigueredoMonasheesPenínsula ParticipaçõesQualcomm VenturesVenture Capital
0
Facebook Twitter Google +

Categories

  • Deals
  • Exits
  • Regulatory
  • M&A
  • New Funds & Firms
  • Partnerships

Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.






Which LAVCA Newsletter would you like to receive?

Tweets

  • "According to LAVCA Data, VC investment into Latin American fintech totaled USD1.2b in the first quarter of 2022."… https://t.co/oikd3BXiCU

    24-Jun-2022

    Reply Retweet Favorite
  • Felicitaciones a la Directora Ejecutiva de LAVCA @lavca_org Ángela María Tafur @naitafur quien se ha incorporado al… https://t.co/qjHgnmFPS3

    14-Jun-2022

    Reply Retweet Favorite
  • LAVCA's Director of Venture Capital @crdelavega_ shares insights with @TechCrunch's @bayareawriter on the latest d… https://t.co/krypDTI5NE

    14-Jun-2022

    Reply Retweet Favorite
  • Congratulations to LAVCA's Executive Director @naitafur who has joined the Board of Directors of @GRUPOSURA. https://t.co/47bv5fyVhT

    13-Jun-2022

    Reply Retweet Favorite
  • In 2018, @_AquaCapital invested in agricultural biologicals platform @Biotropbr. In 3 years, the company has reduce… https://t.co/PDu5zkchTs

    13-Jun-2022

    Reply Retweet Favorite

Keep in touch

Twitter Linkedin Youtube

About LAVCA

 

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Office

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

Explore LAVCA.org

  • About LAVCA
  • Board, Team, & Advisors
  • Media
  • Contact Us
  • Membership Benefits
  • Members Only Access
  • Education and Programs
  • Research
  • Policy
  • LAVCA VC
  • Contact Us

@2020 - LAVCA. All Rights Reserved.


Back To Top